Neonc Technologies
NTHI | NASDAQ
$4.54
-$0.37 (-7.54%)
At close: Nov 16, 2026, 4:00 PM ET
$4.47
-$0.07 (-1.54%)
After-hours:
Nov 16, 2026, 7:57 PM ET
Neonc Technologies Company Profile
Company profile explainedCompany Profile
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Key Executives
| Name | Position |
|---|---|
| Amir Farrokh Heshmatpour | President, Chief Executive Officer, Executive Chairman & Secretary |
| Keithly A. Garnett | Chief Financial Officer |
| David Choi | Chief Accounting Officer |
| Josh Neman-Ebrahim | Chief Clinical Officer |
| Thomas C. Chen | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 22, 2026 | 8-K | Current Report |
| Oct 15, 2026 | 3 | Filing |
| Oct 15, 2026 | 8-K | Current Report |
| Sep 28, 2026 | 8-K | Current Report |
| Sep 21, 2026 | 8-K | Current Report |
| Sep 18, 2026 | 4 | Filing |
| Sep 17, 2026 | 8-K | Current Report |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
Neonc Technologies
| Country | United States |
| IPO Date | Mar 26, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Amir Farrokh Heshmatpour |
Contact Details
23975 Park Sorrento Calabasas,
California 91302 United States
Stock Details
| Ticker Symbol | NTHI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001979414 |
| CUSIP Number | 64051A101 |
| ISIN Number | US64051A1016 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove NTHI